Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 1,968.20
-5.60 (-0.28%)
At close: Dec 5, 2025
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 555.43 billion as of December 5, 2025. Its market cap has increased by 32.48% in one year.
Market Cap
555.43B
Enterprise Value
540.76B
Revenue
159.97B
Ranking
n/a
PE Ratio
55.00
Stock Price
1,968.20
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 555.43B, an increase of 48,227.34%. That is a compound annual growth rate of 28.68%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,334.88B |
| Divi's Laboratories | 1,713.60B |
| Cipla | 1,228.62B |
| Apollo Hospitals Enterprise | 1,035.39B |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.38B |
| Aurobindo Pharma | 702.13B |
| Fortis Healthcare | 678.14B |